The global market for Terbinafine Hydrochloride Drug was estimated to be worth US$ 614 million in 2023 and is forecast to a readjusted size of US$ 912.6 million by 2030 with a CAGR of 6.4% during the forecast period 2024-2030

Terbinafine Hydrochloride Drug - Market

Terbinafine, sold under the brand name Lamisil among others, an antifungal medication used to treat pityriasis versicolor, fungal nail infections, and ringworm including jock itch and athlete's foot. It is either taken by mouth or applied to the skin as a cream or ointment. The cream and ointment are not effective for nail infections.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Terbinafine Hydrochloride Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Terbinafine Hydrochloride Drug by region & country, by Type, and by Application.

The Terbinafine Hydrochloride Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terbinafine Hydrochloride Drug.

Market Segmentation

Scope of Terbinafine Hydrochloride Drug - Market Report

Report Metric	Details
Report Name	Terbinafine Hydrochloride Drug - Market
Forecasted market size in 2030	US$ 912.6 million
CAGR	6.4%
Forecasted years	2024 - 2030
Segment by Type:	Topical Oral
Segment by Application	Fingernail Infection Toenail Infection Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, GSK, TEVA, Dr. Reddy's Laboratories, CIPLA LTD, TARO, InvaGen Pharmaceuticals, Breckenridge Pharmaceutical, Harris Pharmaceutical, Glenmark, Orchid Healthcare, APOTEX, Jilin Wantong Group, Cussess, Hubei Hengan Fulin Pharm, Xiuzheng Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Terbinafine Hydrochloride Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Terbinafine Hydrochloride Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Terbinafine Hydrochloride Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Terbinafine Hydrochloride Drug - Market size in 2030?

Ans: The Terbinafine Hydrochloride Drug - Market size in 2030 will be US$ 912.6 million.

Who are the main players in the Terbinafine Hydrochloride Drug - Market report?

Ans: The main players in the Terbinafine Hydrochloride Drug - Market are Novartis, GSK, TEVA, Dr. Reddy's Laboratories, CIPLA LTD, TARO, InvaGen Pharmaceuticals, Breckenridge Pharmaceutical, Harris Pharmaceutical, Glenmark, Orchid Healthcare, APOTEX, Jilin Wantong Group, Cussess, Hubei Hengan Fulin Pharm, Xiuzheng Pharmaceutical

What are the Application segmentation covered in the Terbinafine Hydrochloride Drug - Market report?

Ans: The Applications covered in the Terbinafine Hydrochloride Drug - Market report are Fingernail Infection, Toenail Infection, Others

What are the Type segmentation covered in the Terbinafine Hydrochloride Drug - Market report?

Ans: The Types covered in the Terbinafine Hydrochloride Drug - Market report are Topical, Oral

1 Market Overview

1.1 Terbinafine Hydrochloride Drug Product Introduction

1.2 Global Terbinafine Hydrochloride Drug Market Size Forecast

1.2.1 Global Terbinafine Hydrochloride Drug Sales Value (2019-2030)

1.2.2 Global Terbinafine Hydrochloride Drug Sales Volume (2019-2030)

1.2.3 Global Terbinafine Hydrochloride Drug Sales Price (2019-2030)

1.3 Terbinafine Hydrochloride Drug Market Trends & Drivers

1.3.1 Terbinafine Hydrochloride Drug Industry Trends

1.3.2 Terbinafine Hydrochloride Drug Market Drivers & Opportunity

1.3.3 Terbinafine Hydrochloride Drug Market Challenges

1.3.4 Terbinafine Hydrochloride Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Terbinafine Hydrochloride Drug Players Revenue Ranking (2023)

2.2 Global Terbinafine Hydrochloride Drug Revenue by Company (2019-2024)

2.3 Global Terbinafine Hydrochloride Drug Players Sales Volume Ranking (2023)

2.4 Global Terbinafine Hydrochloride Drug Sales Volume by Company Players (2019-2024)

2.5 Global Terbinafine Hydrochloride Drug Average Price by Company (2019-2024)

2.6 Key Manufacturers Terbinafine Hydrochloride Drug Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Terbinafine Hydrochloride Drug Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Terbinafine Hydrochloride Drug

2.9 Terbinafine Hydrochloride Drug Market Competitive Analysis

2.9.1 Terbinafine Hydrochloride Drug Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Terbinafine Hydrochloride Drug Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Terbinafine Hydrochloride Drug as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Topical

3.1.2 Oral

3.2 Global Terbinafine Hydrochloride Drug Sales Value by Type

3.2.1 Global Terbinafine Hydrochloride Drug Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Terbinafine Hydrochloride Drug Sales Value, by Type (2019-2030)

3.2.3 Global Terbinafine Hydrochloride Drug Sales Value, by Type (%) (2019-2030)

3.3 Global Terbinafine Hydrochloride Drug Sales Volume by Type

3.3.1 Global Terbinafine Hydrochloride Drug Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Terbinafine Hydrochloride Drug Sales Volume, by Type (2019-2030)

3.3.3 Global Terbinafine Hydrochloride Drug Sales Volume, by Type (%) (2019-2030)

3.4 Global Terbinafine Hydrochloride Drug Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Fingernail Infection

4.1.2 Toenail Infection

4.1.3 Others

4.2 Global Terbinafine Hydrochloride Drug Sales Value by Application

4.2.1 Global Terbinafine Hydrochloride Drug Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Terbinafine Hydrochloride Drug Sales Value, by Application (2019-2030)

4.2.3 Global Terbinafine Hydrochloride Drug Sales Value, by Application (%) (2019-2030)

4.3 Global Terbinafine Hydrochloride Drug Sales Volume by Application

4.3.1 Global Terbinafine Hydrochloride Drug Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Terbinafine Hydrochloride Drug Sales Volume, by Application (2019-2030)

4.3.3 Global Terbinafine Hydrochloride Drug Sales Volume, by Application (%) (2019-2030)

4.4 Global Terbinafine Hydrochloride Drug Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Terbinafine Hydrochloride Drug Sales Value by Region

5.1.1 Global Terbinafine Hydrochloride Drug Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Terbinafine Hydrochloride Drug Sales Value by Region (2019-2024)

5.1.3 Global Terbinafine Hydrochloride Drug Sales Value by Region (2025-2030)

5.1.4 Global Terbinafine Hydrochloride Drug Sales Value by Region (%), (2019-2030)

5.2 Global Terbinafine Hydrochloride Drug Sales Volume by Region

5.2.1 Global Terbinafine Hydrochloride Drug Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Terbinafine Hydrochloride Drug Sales Volume by Region (2019-2024)

5.2.3 Global Terbinafine Hydrochloride Drug Sales Volume by Region (2025-2030)

5.2.4 Global Terbinafine Hydrochloride Drug Sales Volume by Region (%), (2019-2030)

5.3 Global Terbinafine Hydrochloride Drug Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Terbinafine Hydrochloride Drug Sales Value, 2019-2030

5.4.2 North America Terbinafine Hydrochloride Drug Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Terbinafine Hydrochloride Drug Sales Value, 2019-2030

5.5.2 Europe Terbinafine Hydrochloride Drug Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Terbinafine Hydrochloride Drug Sales Value, 2019-2030

5.6.2 Asia Pacific Terbinafine Hydrochloride Drug Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Terbinafine Hydrochloride Drug Sales Value, 2019-2030

5.7.2 South America Terbinafine Hydrochloride Drug Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Terbinafine Hydrochloride Drug Sales Value, 2019-2030

5.8.2 Middle East & Africa Terbinafine Hydrochloride Drug Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Terbinafine Hydrochloride Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Terbinafine Hydrochloride Drug Sales Value

6.2.1 Key Countries/Regions Terbinafine Hydrochloride Drug Sales Value, 2019-2030

6.2.2 Key Countries/Regions Terbinafine Hydrochloride Drug Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Terbinafine Hydrochloride Drug Sales Value, 2019-2030

6.3.2 United States Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Terbinafine Hydrochloride Drug Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Terbinafine Hydrochloride Drug Sales Value, 2019-2030

6.4.2 Europe Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Terbinafine Hydrochloride Drug Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Terbinafine Hydrochloride Drug Sales Value, 2019-2030

6.5.2 China Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

6.5.3 China Terbinafine Hydrochloride Drug Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Terbinafine Hydrochloride Drug Sales Value, 2019-2030

6.6.2 Japan Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Terbinafine Hydrochloride Drug Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Terbinafine Hydrochloride Drug Sales Value, 2019-2030

6.7.2 South Korea Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Terbinafine Hydrochloride Drug Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Terbinafine Hydrochloride Drug Sales Value, 2019-2030

6.8.2 Southeast Asia Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Terbinafine Hydrochloride Drug Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Terbinafine Hydrochloride Drug Sales Value, 2019-2030

6.9.2 India Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

6.9.3 India Terbinafine Hydrochloride Drug Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Novartis

7.1.1 Novartis Company Information

7.1.2 Novartis Introduction and Business Overview

7.1.3 Novartis Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Novartis Terbinafine Hydrochloride Drug Product Offerings

7.1.5 Novartis Recent Development

7.2 GSK

7.2.1 GSK Company Information

7.2.2 GSK Introduction and Business Overview

7.2.3 GSK Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.2.4 GSK Terbinafine Hydrochloride Drug Product Offerings

7.2.5 GSK Recent Development

7.3 TEVA

7.3.1 TEVA Company Information

7.3.2 TEVA Introduction and Business Overview

7.3.3 TEVA Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.3.4 TEVA Terbinafine Hydrochloride Drug Product Offerings

7.3.5 TEVA Recent Development

7.4 Dr. Reddy's Laboratories

7.4.1 Dr. Reddy's Laboratories Company Information

7.4.2 Dr. Reddy's Laboratories Introduction and Business Overview

7.4.3 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Offerings

7.4.5 Dr. Reddy's Laboratories Recent Development

7.5 CIPLA LTD

7.5.1 CIPLA LTD Company Information

7.5.2 CIPLA LTD Introduction and Business Overview

7.5.3 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.5.4 CIPLA LTD Terbinafine Hydrochloride Drug Product Offerings

7.5.5 CIPLA LTD Recent Development

7.6 TARO

7.6.1 TARO Company Information

7.6.2 TARO Introduction and Business Overview

7.6.3 TARO Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.6.4 TARO Terbinafine Hydrochloride Drug Product Offerings

7.6.5 TARO Recent Development

7.7 InvaGen Pharmaceuticals

7.7.1 InvaGen Pharmaceuticals Company Information

7.7.2 InvaGen Pharmaceuticals Introduction and Business Overview

7.7.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.7.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Offerings

7.7.5 InvaGen Pharmaceuticals Recent Development

7.8 Breckenridge Pharmaceutical

7.8.1 Breckenridge Pharmaceutical Company Information

7.8.2 Breckenridge Pharmaceutical Introduction and Business Overview

7.8.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Offerings

7.8.5 Breckenridge Pharmaceutical Recent Development

7.9 Harris Pharmaceutical

7.9.1 Harris Pharmaceutical Company Information

7.9.2 Harris Pharmaceutical Introduction and Business Overview

7.9.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Offerings

7.9.5 Harris Pharmaceutical Recent Development

7.10 Glenmark

7.10.1 Glenmark Company Information

7.10.2 Glenmark Introduction and Business Overview

7.10.3 Glenmark Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Glenmark Terbinafine Hydrochloride Drug Product Offerings

7.10.5 Glenmark Recent Development

7.11 Orchid Healthcare

7.11.1 Orchid Healthcare Company Information

7.11.2 Orchid Healthcare Introduction and Business Overview

7.11.3 Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Orchid Healthcare Terbinafine Hydrochloride Drug Product Offerings

7.11.5 Orchid Healthcare Recent Development

7.12 APOTEX

7.12.1 APOTEX Company Information

7.12.2 APOTEX Introduction and Business Overview

7.12.3 APOTEX Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.12.4 APOTEX Terbinafine Hydrochloride Drug Product Offerings

7.12.5 APOTEX Recent Development

7.13 Jilin Wantong Group

7.13.1 Jilin Wantong Group Company Information

7.13.2 Jilin Wantong Group Introduction and Business Overview

7.13.3 Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Jilin Wantong Group Terbinafine Hydrochloride Drug Product Offerings

7.13.5 Jilin Wantong Group Recent Development

7.14 Cussess

7.14.1 Cussess Company Information

7.14.2 Cussess Introduction and Business Overview

7.14.3 Cussess Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Cussess Terbinafine Hydrochloride Drug Product Offerings

7.14.5 Cussess Recent Development

7.15 Hubei Hengan Fulin Pharm

7.15.1 Hubei Hengan Fulin Pharm Company Information

7.15.2 Hubei Hengan Fulin Pharm Introduction and Business Overview

7.15.3 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Offerings

7.15.5 Hubei Hengan Fulin Pharm Recent Development

7.16 Xiuzheng Pharmaceutical

7.16.1 Xiuzheng Pharmaceutical Company Information

7.16.2 Xiuzheng Pharmaceutical Introduction and Business Overview

7.16.3 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2019-2024)

7.16.4 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Offerings

7.16.5 Xiuzheng Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Terbinafine Hydrochloride Drug Industrial Chain

8.2 Terbinafine Hydrochloride Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Terbinafine Hydrochloride Drug Sales Model

8.5.2 Sales Channel

8.5.3 Terbinafine Hydrochloride Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Novartis

GSK

TEVA

Dr. Reddy’s Laboratories

Cipla Ltd

Taro

Invagen Pharmaceuticals

Breckenridge Pharmaceutical

Harris Pharmaceutical

Hubei Hengan Fulin Pharm

Xiuzheng Pharmaceutical

List of Tables

Table 1. Terbinafine Hydrochloride Drug Market Trends

Table 2. Terbinafine Hydrochloride Drug Market Drivers & Opportunity

Table 3. Terbinafine Hydrochloride Drug Market Challenges

Table 4. Terbinafine Hydrochloride Drug Market Restraints

Table 5. Global Terbinafine Hydrochloride Drug Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Terbinafine Hydrochloride Drug Revenue Market Share by Company (2019-2024)

Table 7. Global Terbinafine Hydrochloride Drug Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Terbinafine Hydrochloride Drug Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Terbinafine Hydrochloride Drug Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Terbinafine Hydrochloride Drug Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Terbinafine Hydrochloride Drug Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Terbinafine Hydrochloride Drug

Table 13. Global Terbinafine Hydrochloride Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Terbinafine Hydrochloride Drug as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Terbinafine Hydrochloride Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Terbinafine Hydrochloride Drug Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Terbinafine Hydrochloride Drug Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Terbinafine Hydrochloride Drug Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Terbinafine Hydrochloride Drug Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Terbinafine Hydrochloride Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Terbinafine Hydrochloride Drug Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Terbinafine Hydrochloride Drug Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Terbinafine Hydrochloride Drug Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Terbinafine Hydrochloride Drug Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Terbinafine Hydrochloride Drug Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Terbinafine Hydrochloride Drug Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Terbinafine Hydrochloride Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Terbinafine Hydrochloride Drug Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Terbinafine Hydrochloride Drug Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Terbinafine Hydrochloride Drug Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Terbinafine Hydrochloride Drug Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Terbinafine Hydrochloride Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Terbinafine Hydrochloride Drug Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Terbinafine Hydrochloride Drug Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Terbinafine Hydrochloride Drug Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Terbinafine Hydrochloride Drug Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Terbinafine Hydrochloride Drug Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Terbinafine Hydrochloride Drug Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Terbinafine Hydrochloride Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Terbinafine Hydrochloride Drug Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Terbinafine Hydrochloride Drug Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Terbinafine Hydrochloride Drug Sales Value by Region (2019-2024) & (%)

Table 44. Global Terbinafine Hydrochloride Drug Sales Value by Region (2025-2030) & (%)

Table 45. Global Terbinafine Hydrochloride Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Terbinafine Hydrochloride Drug Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Terbinafine Hydrochloride Drug Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Terbinafine Hydrochloride Drug Sales Volume by Region (2019-2024) & (%)

Table 49. Global Terbinafine Hydrochloride Drug Sales Volume by Region (2025-2030) & (%)

Table 50. Global Terbinafine Hydrochloride Drug Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Terbinafine Hydrochloride Drug Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Terbinafine Hydrochloride Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Terbinafine Hydrochloride Drug Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Terbinafine Hydrochloride Drug Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Terbinafine Hydrochloride Drug Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Terbinafine Hydrochloride Drug Sales Volume, (2025-2030) & (K Units)

Table 57. Novartis Company Information

Table 58. Novartis Introduction and Business Overview

Table 59. Novartis Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Novartis Terbinafine Hydrochloride Drug Product Offerings

Table 61. Novartis Recent Development

Table 62. GSK Company Information

Table 63. GSK Introduction and Business Overview

Table 64. GSK Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. GSK Terbinafine Hydrochloride Drug Product Offerings

Table 66. GSK Recent Development

Table 67. TEVA Company Information

Table 68. TEVA Introduction and Business Overview

Table 69. TEVA Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. TEVA Terbinafine Hydrochloride Drug Product Offerings

Table 71. TEVA Recent Development

Table 72. Dr. Reddy's Laboratories Company Information

Table 73. Dr. Reddy's Laboratories Introduction and Business Overview

Table 74. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Offerings

Table 76. Dr. Reddy's Laboratories Recent Development

Table 77. CIPLA LTD Company Information

Table 78. CIPLA LTD Introduction and Business Overview

Table 79. CIPLA LTD Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. CIPLA LTD Terbinafine Hydrochloride Drug Product Offerings

Table 81. CIPLA LTD Recent Development

Table 82. TARO Company Information

Table 83. TARO Introduction and Business Overview

Table 84. TARO Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. TARO Terbinafine Hydrochloride Drug Product Offerings

Table 86. TARO Recent Development

Table 87. InvaGen Pharmaceuticals Company Information

Table 88. InvaGen Pharmaceuticals Introduction and Business Overview

Table 89. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Offerings

Table 91. InvaGen Pharmaceuticals Recent Development

Table 92. Breckenridge Pharmaceutical Company Information

Table 93. Breckenridge Pharmaceutical Introduction and Business Overview

Table 94. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Offerings

Table 96. Breckenridge Pharmaceutical Recent Development

Table 97. Harris Pharmaceutical Company Information

Table 98. Harris Pharmaceutical Introduction and Business Overview

Table 99. Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Offerings

Table 101. Harris Pharmaceutical Recent Development

Table 102. Glenmark Company Information

Table 103. Glenmark Introduction and Business Overview

Table 104. Glenmark Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Glenmark Terbinafine Hydrochloride Drug Product Offerings

Table 106. Glenmark Recent Development

Table 107. Orchid Healthcare Company Information

Table 108. Orchid Healthcare Introduction and Business Overview

Table 109. Orchid Healthcare Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Orchid Healthcare Terbinafine Hydrochloride Drug Product Offerings

Table 111. Orchid Healthcare Recent Development

Table 112. APOTEX Company Information

Table 113. APOTEX Introduction and Business Overview

Table 114. APOTEX Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. APOTEX Terbinafine Hydrochloride Drug Product Offerings

Table 116. APOTEX Recent Development

Table 117. Jilin Wantong Group Company Information

Table 118. Jilin Wantong Group Introduction and Business Overview

Table 119. Jilin Wantong Group Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 120. Jilin Wantong Group Terbinafine Hydrochloride Drug Product Offerings

Table 121. Jilin Wantong Group Recent Development

Table 122. Cussess Company Information

Table 123. Cussess Introduction and Business Overview

Table 124. Cussess Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 125. Cussess Terbinafine Hydrochloride Drug Product Offerings

Table 126. Cussess Recent Development

Table 127. Hubei Hengan Fulin Pharm Company Information

Table 128. Hubei Hengan Fulin Pharm Introduction and Business Overview

Table 129. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 130. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Offerings

Table 131. Hubei Hengan Fulin Pharm Recent Development

Table 132. Xiuzheng Pharmaceutical Company Information

Table 133. Xiuzheng Pharmaceutical Introduction and Business Overview

Table 134. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 135. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Offerings

Table 136. Xiuzheng Pharmaceutical Recent Development

Table 137. Key Raw Materials Lists

Table 138. Raw Materials Key Suppliers Lists

Table 139. Terbinafine Hydrochloride Drug Downstream Customers

Table 140. Terbinafine Hydrochloride Drug Distributors List

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Terbinafine Hydrochloride Drug Product Picture

Figure 2. Global Terbinafine Hydrochloride Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Terbinafine Hydrochloride Drug Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Terbinafine Hydrochloride Drug Sales Volume (2019-2030) & (K Units)

Figure 5. Global Terbinafine Hydrochloride Drug Sales Price (2019-2030) & (USD/Unit)

Figure 6. Terbinafine Hydrochloride Drug Report Years Considered

Figure 7. Global Terbinafine Hydrochloride Drug Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Terbinafine Hydrochloride Drug Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Terbinafine Hydrochloride Drug Revenue in 2023

Figure 10. Terbinafine Hydrochloride Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Topical Picture

Figure 12. Oral Picture

Figure 13. Global Terbinafine Hydrochloride Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Terbinafine Hydrochloride Drug Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Terbinafine Hydrochloride Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Terbinafine Hydrochloride Drug Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Terbinafine Hydrochloride Drug Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Fingernail Infection

Figure 19. Product Picture of Toenail Infection

Figure 20. Product Picture of Others

Figure 21. Global Terbinafine Hydrochloride Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Terbinafine Hydrochloride Drug Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Terbinafine Hydrochloride Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Terbinafine Hydrochloride Drug Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Terbinafine Hydrochloride Drug Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Terbinafine Hydrochloride Drug Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Terbinafine Hydrochloride Drug Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Terbinafine Hydrochloride Drug Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Terbinafine Hydrochloride Drug Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Terbinafine Hydrochloride Drug Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Terbinafine Hydrochloride Drug Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Terbinafine Hydrochloride Drug Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Terbinafine Hydrochloride Drug Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Terbinafine Hydrochloride Drug Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Terbinafine Hydrochloride Drug Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Terbinafine Hydrochloride Drug Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Terbinafine Hydrochloride Drug Sales Volume (%), (2019-2030)

Figure 38. United States Terbinafine Hydrochloride Drug Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Terbinafine Hydrochloride Drug Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Terbinafine Hydrochloride Drug Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Terbinafine Hydrochloride Drug Sales Value by Application (%), 2023 VS 2030

Figure 44. China Terbinafine Hydrochloride Drug Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

Figure 46. China Terbinafine Hydrochloride Drug Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Terbinafine Hydrochloride Drug Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Terbinafine Hydrochloride Drug Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Terbinafine Hydrochloride Drug Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Terbinafine Hydrochloride Drug Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Terbinafine Hydrochloride Drug Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Terbinafine Hydrochloride Drug Sales Value by Application (%), 2023 VS 2030

Figure 56. India Terbinafine Hydrochloride Drug Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Terbinafine Hydrochloride Drug Sales Value by Type (%), 2023 VS 2030

Figure 58. India Terbinafine Hydrochloride Drug Sales Value by Application (%), 2023 VS 2030

Figure 59. Terbinafine Hydrochloride Drug Industrial Chain

Figure 60. Terbinafine Hydrochloride Drug Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions